These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35475037)

  • 1. An
    Prieto-Martínez FD; Fernández-de Gortari E; Medina-Franco JL; Espinoza-Fonseca LM
    Artif Intell Life Sci; 2021 Dec; 1():. PubMed ID: 35475037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic polypharmacology: A new frontier for epi-drug discovery.
    Tomaselli D; Lucidi A; Rotili D; Mai A
    Med Res Rev; 2020 Jan; 40(1):190-244. PubMed ID: 31218726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial
    Ganai SA; Abdullah E; Rashid R; Altaf M
    Front Mol Neurosci; 2017; 10():357. PubMed ID: 29170627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting HIV/HCV Coinfection Using a Machine Learning-Based Multiple Quantitative Structure-Activity Relationships (Multiple QSAR) Method.
    Wei Y; Li W; Du T; Hong Z; Lin J
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the Structural Diversity of DNA Methyltransferase Inhibitors.
    Juárez-Mercado KE; Prieto-Martínez FD; Sánchez-Cruz N; Peña-Castillo A; Prada-Gracia D; Medina-Franco JL
    Pharmaceuticals (Basel); 2020 Dec; 14(1):. PubMed ID: 33375520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-silico discovery of dual active molecule to restore synaptic wiring against autism spectrum disorder via HDAC2 and H3R inhibition.
    Raja A; Shekhar N; Singh H; Prakash A; Medhi B
    PLoS One; 2022; 17(7):e0268139. PubMed ID: 35877665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel hit compounds as potential HDAC1 inhibitors: The case of ligand- and structure-based virtual screening.
    Sirous H; Campiani G; Calderone V; Brogi S
    Comput Biol Med; 2021 Oct; 137():104808. PubMed ID: 34478925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity Landscape and Molecular Modeling to Explore the SAR of Dual Epigenetic Inhibitors: A Focus on G9a and DNMT1.
    López-López E; Prieto-Martínez FD; Medina-Franco JL
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30544967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 7-Aminoalkoxy-Quinazolines from Epigenetic Focused Libraries Are Potent and Selective Inhibitors of DNA Methyltransferase 1.
    Medina-Franco JL; López-López E; Martínez-Fernández LP
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Computational Approach for the Discovery of Novel DNA Methyltransferase Inhibitors.
    Kritsi E; Christodoulou P; Tsiaka T; Georgiadis P; Zervou M
    Curr Issues Mol Biol; 2024 Apr; 46(4):3394-3407. PubMed ID: 38666943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in multitarget-directed ligands via in silico drug discovery.
    Maddeboina K; Yada B; Kumari S; McHale C; Pal D; Durden DL
    Drug Discov Today; 2024 Mar; 29(3):103904. PubMed ID: 38280625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone Deacetylase Inhibitors as Multitarget-Directed Epi-Drugs in Blocking PI3K Oncogenic Signaling: A Polypharmacology Approach.
    Ranganna K; Selvam C; Shivachar A; Yousefipour Z
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33147762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Silico Identification of Multi-Target Ligands as Promising Hit Compounds for Neurodegenerative Diseases Drug Development.
    Alov P; Stoimenov H; Lessigiarska I; Pencheva T; Tzvetkov NT; Pajeva I; Tsakovska I
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of PAR4 Upregulates p16 through Inhibition of DNMT1 and HDAC2 Expression via MAPK Signals in Esophageal Squamous Cell Carcinoma Cells.
    Wang M; An S; Wang D; Ji H; Guo X; Wang Z
    J Immunol Res; 2018; 2018():4735752. PubMed ID: 30363984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docking of a novel DNA methyltransferase inhibitor identified from high-throughput screening: insights to unveil inhibitors in chemical databases.
    Medina-Franco JL; Yoo J
    Mol Divers; 2013 May; 17(2):337-44. PubMed ID: 23447100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal chromatin-modifying enzymes are pivotal for scopolamine-induced synaptic plasticity gene expression changes and memory impairment.
    Singh P; Konar A; Kumar A; Srivas S; Thakur MK
    J Neurochem; 2015 Aug; 134(4):642-51. PubMed ID: 25982413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring EZH2-Proteasome Dual-Targeting Drug Discovery through a Computational Strategy to Fight Multiple Myeloma.
    Estrada FGA; Miccoli S; Aniceto N; García-Sosa AT; Guedes RC
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design and optimization of pyrimidine- and 1,2,4-triazolo[4,3-a]pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology.
    El Ashry ESH; Awad LF; Teleb M; Ibrahim NA; Abu-Serie MM; Abd Al Moaty MN
    Bioorg Chem; 2020 Mar; 96():103616. PubMed ID: 32032847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation.
    Kuck D; Singh N; Lyko F; Medina-Franco JL
    Bioorg Med Chem; 2010 Jan; 18(2):822-9. PubMed ID: 20006515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a Novel HDAC2 Inhibitor by a Scaffold-Merging Hybrid Query.
    Basant N; Lin X; Reid TE; Karla PK; Wang XS
    Comb Chem High Throughput Screen; 2015; 18(7):693-700. PubMed ID: 26144283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.